HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 22235993, compound → HCID 22235841, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 22235993 | HCID 22235993 | — |
| Reactant | HCID 86594552 | HCID 86594552 | — |
| Product | HCID 22235841 | HCID 22235841 | — |
Reaction Steps
Using the procedure described in Example 1 where tert-butyl 4-{4′-[((1S)-1-{[(cyanomethyl)amino]carbonyl}-3-methylbutyl)amino][1,1′-biphenyl]-4-yl}-1-piperazinecarboxylate is substituted for tert-butyl 4-[4′-({2-[(cyanomethyl)amino]-1-[(1-methylcyclopropyl)methyl]-2-oxoethyl}thio)-1,1′-biphenyl-4-yl]piperazine-1-carboxylate, N-(cyanomethyl)-3-(1-methylcyclopropyl)-2-[(4′-piperazin-1-yl-1,1′-biphenyl-4-yl)thio]propanamide was obtained after crystallization in EtOAc and hexane (1:2) as a beige solid. MS (+ESI): 435.2 [M+1]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07012075B2 |
| Source dataset | uspto-grants-2006_03 |
| ORD ID | ord-3235293c1f7d4dda8cbb717a2ea12aa7 |
| Source note | uspto-grants-2006_03 |